Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LPCN on Nasdaq
Shares outstanding
5,555,556
Price per share
$4.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
529,307
Total reported value
$1,512,291
% of total 13F portfolios
0%
Share change
+851
Value change
+$2,462
Number of holders
21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Squadron Capital Management LLC 9% $1,435,000 500,000 Squadron Capital Management LLC 18 Dec 2025

As of 30 Sep 2025, 21 institutional investors reported holding 529,307 shares of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN). This represents 9.5% of the company’s total 5,555,556 outstanding shares.

Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 529,307 $1,512,291 +$2,462 $2.85 21
2025 Q2 528,456 $1,670,206 +$34,959 $3.16 18
2025 Q1 517,473 $1,645,594 +$97,947 $3.18 19
2024 Q4 486,671 $2,375,002 -$289,398 $4.88 17
2024 Q3 544,524 $2,444,950 +$9,929 $4.49 18
2024 Q2 531,604 $4,380,488 +$476,120 $8.24 18
2024 Q1 473,865 $2,464,434 -$16,115 $5.20 17
2023 Q4 483,800 $1,345,652 -$46,888 $2.78 18
2023 Q3 499,811 $1,484,978 -$7,404 $2.97 20
2023 Q2 477,372 $2,400,563 +$2,397,563 $5.03 22
2021 Q4 0 $0 -$1,090 $4.20 0
2021 Q3 1,000 $1,090 $1.09 1
2021 Q2 1,000 $1,400 $1.40 1
2021 Q1 1,000 $1,510 +$1,510 $1.51 1